Bone Marrow Transplant Market Focusing on Current Trends, Leading with Top Key Players

Bone marrow transplantation, also referred as hematopoietic stem cell transplantation is the process of replacing diseased or damaged bone marrow or bone marrow stem cells with healthy tissue. Bone marrow is a soft vascular tissue present in the interior of long bones, which is primarily responsible for hematopoiesis (formation of blood cells), production of lymphocytes, and storage of a fat. Bone marrow transplantation procedure is recommended to treat severe stages of leukemia, Hodgkin and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia etc. In 2015, more than 75,000 bone marrow transplants were performed globally and the count is expected to increase by approximately 25% by the end of 2020.

Depending on the source of bone marrow or stem cells, bone marrow transplant procedures are classified as peripheral stem cell transplant (PSCT) or conventional bone marrow transplant. The high potential of the bone marrow transplants and the ongoing researches in the field to reduce the risks and side effects of the procedure will take the market to a new high and provide better healthcare to millions of people in the world.

Bone Marrow Transplant Market: Drivers and Restraints

Increasing worldwide prevalence of cancers and anemia is the major driver for the growth of global bone marrow transplant market. Moreover, advances in technology, improving healthcare infrastructure, emerging indications of bone marrow transplant for heart and neuronal disorders, growing investment in logistic services, increasing per capita healthcare expenditure are some other factors expected to flourish the global bone marrow transplantation market.

However, tremendous cost of the treatment, scarcity of bone marrow donors and uncertainty of reimbursement in several countries are some major restraints for the growth of global bone marrow transplantation market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1354

Bone Marrow Transplant Market: Overview

Autologous bone marrow transplant segment of transplant type is expected to hold the major share in the global bone marrow transplant market owing to low treatment cost and high success rate. Leukemia being the most potential disease eligible for bone marrow transplant, is anticipated to contribute highest share in the global bone marrow transplant market.

Hospital end user segment contributes major market share in global bone marrow transplant market owing to the requirement for advanced healthcare infrastructure for the procedure. Commercialization of stem cell therapies and expansion of them for clinical use is anticipated to cause surge in global bone marrow transplant market over the forecast period of 2016-2026.

Bone Marrow Transplant Market: Region wise Overview

Geographically, global bone marrow transplant market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.Europe will continue to lead the global bone marrow transplant market due to high density of bone marrow transplant centers and expanding bone marrow registries.

Latin America is anticipated to witness rapid increase in volume of bone marrow transplant market owing to high number of potential candidates for the procedure. Increasing number of bone marrow transplant teams in North America is foreseen to boost the bone marrow transplant market in the region.

For any queries linked with the report, ask an analyst >>

https://www.futuremarketinsights.com/ask-question/rep-gb-1354

Bone Marrow Transplant Market: Key Players

Some of the key players in global bone marrow transplant market are Lonza Group Ltd., Merck Millipore Corporation, Sanofi-Aventis LLC., AllCells LLC., STEMCELL Technologies, ATCC Inc., Hemacare Corporation, Cellular Dynamics International, ReachBio LLC., Conversant Bio, abm Inc., PromoCell GmbH, Cruline Human biospecime PRO, Lifeline Cell Technology, Mesoblast Ltd. and others.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1354

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The global bone marrow transplant market has been classified on the basis of transplant type, disease indication, end user and geography.